Likely Benign: BS1 is strong because gnomAD v4.1 grpmax FAF exceeds the APC VCEP frequency threshold. Likely Benign: BP1 is supporting because codon 544 lies outside the APC VCEP's beta-catenin-binding repeat exception.
APC is a tumor suppressor gene whose protein acts as a key brake on the Wnt signaling pathway by helping mark the growth-promoting protein beta-catenin for destruction; it also participates in cell migration, adhesion, and apoptosis. Inherited mutations in APC cause familial adenomatous polyposis (FAP), an autosomal dominant condition characterized by numerous colorectal polyps and a very high risk of colorectal cancer, with related forms including attenuated FAP and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). Somatic APC mutations are found in roughly 50-80% of sporadic colorectal cancers, where they act as early tumor-initiating events, and are also observed in some breast, stomach, and prostate cancers. Loss of APC function leaves Wnt signaling abnormally active, driving uncontrolled cell growth, which makes APC a central tumor suppressor in colorectal cancer.
This APC missense variant is considered in the context of APC's role as a tumor-suppressor gene whose inherited loss-of-function variants cause autosomal dominant familial adenomatous polyposis.
Likely Benign: BS1 is strong because gnomAD v4.1 grpmax FAF exceeds the APC VCEP frequency threshold. Likely Benign: BP1 is supporting because codon 544 lies outside the APC VCEP's beta-catenin-binding repeat exception.
European (non-Finnish) 357 / 1,172,130 |
0.03% |
Remaining individuals 12 / 62,114 |
0.019% |
Admixed American 3 / 59,998 |
0.005% |
European (Finnish) 2 / 63,996 |
0.0031% |
African/African American 1 / 74,908 |
0.0013% |
European (non-Finnish) 40 / 128,968 |
0.031% |
Remaining individuals 1 / 7,214 |
0.014% |
European (Finnish) 1 / 25,120 |
0.004% |
Admixed American 1 / 35,394 |
0.0028% |